Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reovirus as a novel oncolytic agent.

Literature DB >> 10772645

Reovirus as a novel oncolytic agent.

K L Norman¹, P W Lee.

Abstract

Entities: Species

Mesh：

Year: 2000 PMID： 10772645 PMCID： PMC300841 DOI： 10.1172/JCI9871

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

32 in total

Review 1. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase.

Authors: X Zou; K Calame
Journal: J Biol Chem Date: 1999-06-25 Impact factor: 5.157

Review 2. The hallmarks of cancer.

Authors: D Hanahan; R A Weinberg
Journal: Cell Date: 2000-01-07 Impact factor: 41.582

3. Reoviruses. A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described.

Authors: A B SABIN
Journal: Science Date: 1959-11-20 Impact factor: 47.728

Review 4. The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomas.

Authors: M Bredel; I F Pollack
Journal: Brain Res Brain Res Rev Date: 1999-04

5. The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection.

Authors: J E Strong; P W Lee
Journal: J Virol Date: 1996-01 Impact factor: 5.103

Review 6. RAS and leukemia: from basic mechanisms to gene-directed therapy.

Authors: D M Beaupre; R Kurzrock
Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544

7. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.

Authors: J E Strong; M C Coffey; D Tang; P Sabinin; P W Lee
Journal: EMBO J Date: 1998-06-15 Impact factor: 11.598

Review 8. Increasing complexity of Ras signaling.

Authors: S L Campbell; R Khosravi-Far; K L Rossman; G J Clark; C J Der
Journal: Oncogene Date: 1998-09-17 Impact factor: 9.867

9. Reovirus type 3 chemoimmunotherapy of murine lymphoma is abrogated by cyclosporine.

Authors: T A Steele; D C Cox
Journal: Cancer Biother Date: 1995

10. Reovirus therapy of tumors with activated Ras pathway.

Authors: M C Coffey; J E Strong; P A Forsyth; P W Lee
Journal: Science Date: 1998-11-13 Impact factor: 47.728

31 in total

1. Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1.

Authors: Jason P Fernandes; Francisca Cristi; Heather E Eaton; Patricia Chen; Sarah Haeflinger; Isabelle Bernard; Mary M Hitt; Maya Shmulevitz
Journal: J Virol Date: 2019-10-29 Impact factor: 5.103

Review 2. Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity.

Authors: Jun Gong; Esha Sachdev; Alain C Mita; Monica M Mita
Journal: World J Methodol Date: 2016-03-26

3. Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation.

Authors: Shashi Gujar; Rebecca Dielschneider; Derek Clements; Erin Helson; Maya Shmulevitz; Paola Marcato; Da Pan; Lu-Zhe Pan; Dae-Gyun Ahn; Abdulaziz Alawadhi; Patrick W K Lee
Journal: Mol Ther Date: 2012-11-13 Impact factor: 11.454

4. Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.

Authors: Kai Li; Haipeng Zhang; Jianguang Qiu; Yuan Lin; Jiankai Liang; Xiao Xiao; Liwu Fu; Fang Wang; Jing Cai; Yaqian Tan; Wenbo Zhu; Wei Yin; Bingzheng Lu; Fan Xing; Lipeng Tang; Min Yan; Jialuo Mai; Yuan Li; Wenli Chen; Pengxin Qiu; Xingwen Su; Guangping Gao; Phillip W L Tai; Jun Hu; Guangmei Yan
Journal: Mol Ther Date: 2015-09-16 Impact factor: 11.454

5. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.

Authors: C R Logg; C K Tai; A Logg; W F Anderson; N Kasahara
Journal: Hum Gene Ther Date: 2001-05-20 Impact factor: 5.695